Showing results (81-90 of 125) with videos related to
Sort By:
Pageof 13
Clinical Pharmacokinetics|July 25, 2025
TDM-Based Tailored Dosing of Durvalumab in Lung Cancer Patients: A Comprehensive Population Pharmacokinetic-Pharmacoeconomic EvaluationFenna de Vries, Eric J F Franssen, Arthur A J Smit, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 29, 2024
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastasesPascale C S Rietveld, Niels A D Guchelaar, Ruben A G van Eerden, et al.International Journal of Cancer|March 16, 2024
Darolutamide does not interfere with OATP-mediated uptake of docetaxelStefan A J Buck, Zahra Talebi, Thomas Drabison, et al.European Journal of Cancer (Oxford, England : 1990)|October 8, 2023
Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)Joanneke K Overbeek, Niels A D Guchelaar, Ma Ida Mohmaed Ali, et al.European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational studyEdwin A Basak, Niels S Vermeer, Karlijn de Joode, et al.Journal for Immunotherapy of Cancer|June 10, 2019
CD45RA<sup>+</sup>CCR7<sup>-</sup> CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabAndre Kunert, Edwin A Basak, Daan P Hurkmans, et al.Pharmaceuticals (Basel, Switzerland)|January 8, 2025
A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for GlioblastomaIoannis Ntafoulis, Stijn L W Koolen, Olaf van Tellingen, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 2, 2023
The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancerSanne M Buijs, Daan C H van Dorst, Marieke J H A Kruip, et al.Frontiers in Pharmacology|December 3, 2021
Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal CancerRuben A G van Eerden, Leni van Doorn, Femke M de Man, et al.Therapeutic Advances in Medical Oncology|March 24, 2022
Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatmentStefan A J Buck, C Louwrens Braal, Maaike M Hofman, et al.Pageof 13